Glusa E, Markwardt F
Institute of Pharmacology and Toxicology, Medical Academy Erfurt, G.D.R.
Arch Int Pharmacodyn Ther. 1988 Nov-Dec;296:66-75.
The vasoconstrictor effect of dihydroergotamine was studied in endothelium-containing and endothelium-denuded rat aortic rings. The integrity of the endothelium was assessed by the relaxant effect of acetylcholine on precontracted aortic rings, which was absent after removal of endothelium by mechanical rubbing or exposure to saponin. Dihydroergotamine (0.01-10 mumol/l) caused no or only a small contractile effect in the presence of endothelium, while in endothelium-denuded aortic rings a pronounced concentration-dependent increase in tension was observed. The 5-HT antagonist cyproheptadine (2 mumol/l) inhibited the dihydroergotamine-induced vasoconstriction, that means, 5-HT receptors are involved in the vasoconstrictor effect. In the presence of endothelium, the contractile effect of dihydroergotamine was enhanced by the guanylate cyclase inhibitor methylene blue (2 mumol/l) and became comparable in magnitude to that observed in deendothelialized preparations. 8-Bromo-cGMP (50 mumol/l) counteracted the potentiating effect of methylene blue. In the presence of cyproheptadine, methylene blue failed to enhance the dihydroergotamine effect. These results might explain the occurrence of undesired vasospastic effects of dihydroergotamine in arterial vessels with endothelial lesions.
在含有内皮和去内皮的大鼠主动脉环中研究了双氢麦角胺的血管收缩作用。通过乙酰胆碱对预收缩主动脉环的舒张作用来评估内皮的完整性,在用机械摩擦或暴露于皂角苷去除内皮后,这种舒张作用消失。双氢麦角胺(0.01 - 10 μmol/L)在内皮存在时无收缩作用或仅有轻微收缩作用,而在去内皮的主动脉环中观察到张力有明显的浓度依赖性增加。5 - 羟色胺拮抗剂赛庚啶(2 μmol/L)抑制双氢麦角胺诱导的血管收缩,这意味着5 - 羟色胺受体参与了血管收缩作用。在内皮存在时,鸟苷酸环化酶抑制剂亚甲蓝(2 μmol/L)增强了双氢麦角胺的收缩作用,其强度与去内皮制剂中观察到的相当。8 - 溴 - 环磷酸鸟苷(50 μmol/L)抵消了亚甲蓝的增强作用。在赛庚啶存在时,亚甲蓝未能增强双氢麦角胺的作用。这些结果可能解释了双氢麦角胺在有内皮损伤的动脉血管中出现不良血管痉挛效应的原因。